Metformin Generics 500 mg film-coated tablets България - български - Изпълнителна агенция по лекарствата

metformin generics 500 mg film-coated tablets

generics (uk) limited - Метформин - 500 mg film-coated tablets

Metformin Generics 850 mg film-coated tablets България - български - Изпълнителна агенция по лекарствата

metformin generics 850 mg film-coated tablets

generics (uk) limited - Метформин - 850 mg film-coated tablets

Metformin Generics 1000 mg film-coated tablets България - български - Изпълнителна агенция по лекарствата

metformin generics 1000 mg film-coated tablets

generics [uk] ltd. - Метформин - 1000 mg film-coated tablets

Lupkynis Европейски съюз - български - EMA (European Medicines Agency)

lupkynis

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - Имуносупресори - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).

Rukobia Европейски съюз - български - EMA (European Medicines Agency)

rukobia

viiv healthcare b.v. - fostemsavir trometamol - ХИВ инфекции - Антивирусни средства за системно приложение - rukobia, in combination with other antiretrovirals, is indicated for the treatment of adults with multidrug resistant hiv-1 infection for whom it is otherwise not possible to construct a suppressive anti-viral regimen.

Livmarli Европейски съюз - български - EMA (European Medicines Agency)

livmarli

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

Opdualag Европейски съюз - български - EMA (European Medicines Agency)

opdualag

bristol-myers squibb pharma eeig - nivolumab, relatlimab - Меланомът - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.

Livtencity Европейски съюз - български - EMA (European Medicines Agency)

livtencity

takeda pharmaceuticals international ag ireland branch - maribavir - Цитомегаловирусни инфекции - Антивирусни средства за системно приложение - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). Трябва да се вземат предвид официалните препоръки за правилното използване на антивирусни лекарства.

Tivicay Европейски съюз - български - EMA (European Medicines Agency)

tivicay

viiv healthcare bv - dolutegravir - ХИВ инфекции - Антивирусни средства за системно приложение - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.

Teriflunomide Mylan Европейски съюз - български - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - Множествена Склероза, Рецидивно-Ремиттирующее - Имуносупресори - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).